抗抑郁药引起的性功能障碍 - - 一项使用VigiBaseTM数据的药监测研究
Rene Zeiss1, Kathrin Malejko1, Bernhard Connemann1
1Department of Psychiatry and Psychotherapy III, University of Ulm, Leimgrubenweg 12-14, 89075 Ulm, Germany.
Pharmaceuticals (Basel, Switzerland)
|July 27, 2024
概括
抗抑郁药,特别是SSRI和SNRIs,经常与性功能障碍有关. 了解这些副作用及其药理动力学联系对于有效的患者护理和治疗坚持至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 性功能障碍是抗抑郁药物的普遍而往往令人痛苦的副作用.
- 这显著影响患者的生活质量和遵守治疗方案.
- 了解与药物相关的特定风险对于临床实践至关重要.
研究的目的:
- 调查各种抗抑郁药和性功能障碍之间的关联.
- 探索抗抑郁药引起的性副作用的药理学基础.
- 提供支持关于抗抑郁药选择的知情临床决策的数据.
主要方法:
- 来自VigiBaseTM的个案安全报告的分析.
- 计算性功能障碍不良事件报告几率比率 (RORs).
- 对RORs和抗抑郁药与神经递质标的抗抑郁药结合亲缘关系之间的相关性分析.
主要成果:
- 针对选择性血清素再吸收抑制剂 (SSRI) 和血清素 - 上腺素再吸收抑制剂 (SNRIs) 发现的高不成比例的性功能障碍报告.
- 对阿戈梅拉丁,布洛普和米尔塔扎的相关报告较少.
- 在胺转运体结合亲和力和性欲副作用之间发现了显著的正相关性 (r = 0.67,p = 0.001).
结论:
- 当处方抗抑郁药时,临床医生必须主动考虑和管理性副作用.
- 药理动力学特性,特别是血清素载体相互作用,与性功能障碍有关.
- 改善患者的结果取决于监测和解决这些不良影响.
相关概念视频
Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Antidepressant Drugs: Overview
413
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
413
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
343
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
343
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
236
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
236
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
110
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
110


